Nature of change: Change in designation from Independent Director to Non-Executive Non-Independent Director
Name and DIN: Dr. Claudio Albrecht (DIN: 10109819)
Effective date: October 27, 2026
Tenure: Dr. Claudio Albrecht shall continue as a Non-Executive Non-Independent Director of the Company, subject to approval of shareholders and liable to retire by rotation in accordance with the Companies Act, 2013 and Articles of Association of the Company.
Brief profile: Dr. Claudio Albrecht is Co-Founder and Managing Partner of Albrecht, Prock & Partners AG, a Zug-based strategic advisory firm focused on pharmaceutical acquisitions and investments. With over three decades of experience in generics industry, he has served as CEO of Ratiopharm Group, Actavis Group and STADA AG. He began his career at Sandoz and later led generics operations across the Netherlands, Germany, and the United States. As CEO of Ratiopharm Group, he led its international expansion and initiated its biosimilars programme. He co-founded CoMeth and later led Actavis through a major turnaround, culminating in its US$6 billion sale to Watson. He also played a key role in the leveraged buyout of STADA AG and in developing a comprehensive diabetes generics platform.
Relationship with other directors: Dr. Claudio Albrecht is not related to any Director of the Company.
Compliance confirmation: Dr. Claudio Albrecht is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other statutory authority.
Governance and Compliance Details
Board meeting details: Meeting held on October 27, 2026, commenced at 09:00 hrs (IST) and concluded at 10:00 hrs (IST)
Approval process: Change approved by Board of Directors based on recommendation of the Nomination and Remuneration Committee
Regulatory basis: Disclosure made under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reference circular: SEBI Circular No. HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 (as amended from time to time)
Company officials: Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635) signed the disclosure
